While there was no overall relationship between neurodegenerative disease biomarkers and myelin content after accounting for age and other demographic factors, we found that age appears to modify the relationship between myelin content and these biomarkers, particularly for pTau181, NfL, and GFAP. The gene discussed is GFAP; the disease is neurodegenerative disease.